Kimmel Cancer Center
Exact Sciences, Jefferson Health to Study Blood-Based Multicancer Early Detection Test
The partners will survey doctors, care coordinators, and patients on metrics like test safety and efficacy, and how to best implement multicancer testing.
Despite the step-up in FDA action against labs offering PGx tests, the success of these programs suggests that access to them isn't being stifled as some feared.